Yahoo Web Search

Search results

1. • 

     AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug

     Zacks via Yahoo Finance· 2 days ago

     The late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...

2. • 

     2 High-Yield Dividend Stocks to Buy Right Now

     The Motley Fool via AOL· 3 days ago

     AbbVie: A top dividend growth stock AbbVie is a powerhouse dividend payer. Apart from its superb yield of 3.87%, the company has also ...

3. • 

     3 No-Brainer Stocks to Buy in June | The Motley Fool

     The Motley Fool· 6 days ago

     You're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and...

4. • California State Teachers Retirement System Acquires 42,587 Shares of AbbVie Inc. (NYSE:ABBV)

     ETF DAILY NEWS· 5 days ago

     California State Teachers Retirement System raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.5% in the 4th quarter, according to the company in ...

5. • AbbVie (ABBV) Could Be a Great Choice

     Zacks· 6 days ago

     While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out ...

6. • 

     AbbVie (ABBV) Could Be a Great Choice

     Zacks via Yahoo Finance· 5 days ago

     Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...

7. • 10 Health Care Stocks With Whale Alerts In Today's Session - AbbVie (NYSE:ABBV), Gilead Sciences...

     Benzinga· 1 day ago

     Here's the list of options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest ...

8. • AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal

     Zacks· 2 days ago

     Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.

9. • 

     7 Overlooked Stocks That Belong in Every Portfolio

     InvestorPlace· 5 days ago

     Overlooked stocks are not necessarily underperforming the market. In some cases, these stocks simply are slow and steady at a time when investors want to...

10. • 

      AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology...

      Benzinga· 5 days ago

      AbbVie ABBV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...